Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Renal Failure

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 92 articles:
HTML format



Single Articles


    March 2021
  1. LOOKSTEIN RA, Haruguchi H, Holden A
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. Reply.
    N Engl J Med. 2021;384:1173-1174.
    PubMed    


  2. PACKER D
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1173.
    PubMed    


  3. MAYUMI T, Okano H
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1172-1173.
    PubMed    


  4. SWINNEN J
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1172.
    PubMed    


  5. DAVIDSON I
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1171-1172.
    PubMed    


  6. BAKRIS GL, Agarwal R, Filippatos G
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2021;384:e42.
    PubMed    


  7. MOURA-NETO JA, Ronco C
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


  8. YOUNG MJ, Fuller PJ
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


  9. EDWARDS NC, Ferro CJ, Townend JN
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


  10. MAKEMBI AB, Mohamadou I, Galichon P
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


  11. BAUMSTEIN D
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


    January 2021
  12. HEERSPINK HJL, Langkilde AM, Wheeler DC
    Dapagliflozin in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2021;384:389-390.
    PubMed    


  13. YASUDA H, Isobe S
    Dapagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2021;384:389.
    PubMed    


  14. VOGT L
    Dapagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2021;384:388-389.
    PubMed    


    December 2020
  15. BAKRIS GL, Agarwal R, Anker SD, Pitt B, et al
    Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2020;383:2219-2229.
    PubMed     Abstract available


    November 2020
  16. BHATT DL, Szarek M, Pitt B, Cannon CP, et al
    Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
    N Engl J Med. 2020 Nov 16. doi: 10.1056/NEJMoa2030186.
    PubMed     Abstract available


    October 2020
  17. WALD R, Bagshaw SM
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. Reply.
    N Engl J Med. 2020;383:1797-1798.
    PubMed    


  18. SU Y, Tu GW, Luo Z
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:1797.
    PubMed    


  19. LUIJNENBURG TWF, Petjak M, de Pont AJM
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:1797.
    PubMed    


  20. BOUCHARD J, Cutter G, Mehta R
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:1796.
    PubMed    


  21. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    PubMed    


  22. INGELFINGER JR, Rosen CJ
    Finerenone - Halting Relative Hyperaldosteronism in Chronic Kidney Disease.
    N Engl J Med. 2020 Oct 23. doi: 10.1056/NEJMe2031382.
    PubMed    


  23. FEIG DI
    Allopurinol and Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:1692.
    PubMed    


  24. BADVE SV, Pascoe EM
    Allopurinol and Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:1691-1692.
    PubMed    


  25. DORIA A, Galecki AT, Mauer M
    Allopurinol and Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:1690-1691.
    PubMed    


  26. FERNANDEZ-PRADO R, Ortiz A, Perez-Gomez MV
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1690.
    PubMed    


  27. MCCORMICK N, Zhang Y, Choi HK
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689-1690.
    PubMed    


  28. CONWAY R
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689.
    PubMed    


  29. PONTICELLI C, Podesta MA
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1688-1689.
    PubMed    


  30. KANG DH, Sanchez-Lozada LG, Johnson RJ
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1687-1688.
    PubMed    


    September 2020
  31. HEERSPINK HJL, Stefansson BV, Correa-Rotter R, Chertow GM, et al
    Dapagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020 Sep 24. doi: 10.1056/NEJMoa2024816.
    PubMed     Abstract available


    August 2020
  32. LOOKSTEIN RA, Haruguchi H, Ouriel K, Weinberg I, et al
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2020;383:733-742.
    PubMed     Abstract available


    July 2020
  33. BAGSHAW SM, Wald R, Adhikari NKJ, Bellomo R, et al
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:240-251.
    PubMed     Abstract available



  34. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMx200016.
    PubMed    


  35. KALANTAR-ZADEH K, Wightman A, Liao S
    Ensuring Choice for People with Kidney Failure - Dialysis, Supportive Care, and Hope.
    N Engl J Med. 2020;383:99.
    PubMed    


  36. KAPLAN JM
    Roxadustat for Anemia in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:e3.
    PubMed    


  37. XIE J, Chen N
    Roxadustat for Anemia in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:e3.
    PubMed    


  38. SHAH HH, Fishbane S
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  39. MOHANDAS R, Segal MS
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  40. ZIELNIOK K, Burdzinska A, Paczek L
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  41. ANKER MS, Butler J, Anker SD
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  42. NISHIOKA R, Kawano M
    Tongue Ulceration from Cytomegalovirus Infection.
    N Engl J Med. 2020;383:67.
    PubMed    


    June 2020
  43. FEIG DI
    Urate-Lowering Therapy and Chronic Kidney Disease Progression.
    N Engl J Med. 2020;382:2567-2568.
    PubMed    


  44. BADVE SV, Pascoe EM, Tiku A, Boudville N, et al
    Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    N Engl J Med. 2020;382:2504-2513.
    PubMed     Abstract available


  45. ANAND S, Staniec A, Montez-Rath M, Vlahos P, et al
    Using GIS Mapping to Track Hot Spots of Kidney Disease in California.
    N Engl J Med. 2020;382:2265-2267.
    PubMed    


    May 2020
  46. FISHBANE S
    Difelikefalin in Hemodialysis Patients with Pruritus. Reply.
    N Engl J Med. 2020;382:2065-2066.
    PubMed    


  47. LIN CH
    Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2020;382:2064-2065.
    PubMed    


  48. MANENTI L, Rossi GM, Fiaccadori E
    Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2020;382:2064.
    PubMed    


  49. BRENNAN F, Davison S, Brown M
    Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2020;382:2064.
    PubMed    


    March 2020
  50. RAMON A, Berthod PE
    Osteitis Fibrosa Cystica.
    N Engl J Med. 2020;382:e15.
    PubMed    


    February 2020
  51. WALSH M, Merkel PA, Peh CA, Szpirt WM, et al
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:622-631.
    PubMed     Abstract available


    January 2020
  52. BLASI M, Stadtler H, Chang J, Hemmersbach-Miller M, et al
    Detection of Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient.
    N Engl J Med. 2020;382:195-197.
    PubMed    


    November 2019
  53. FISHBANE S, Jamal A, Munera C, Wen W, et al
    A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2019 Nov 8. doi: 10.1056/NEJMoa1912770.
    PubMed     Abstract available


    October 2019
  54. SELHORST P, Combrinck CE, Manning K, Botha FCJ, et al
    Longer-Term Outcomes of HIV-Positive-to-HIV-Positive Renal Transplantation.
    N Engl J Med. 2019;381:1387-1389.
    PubMed    


    August 2019
  55. JOHNSON RJ, Wesseling C, Newman LS
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities. Reply.
    N Engl J Med. 2019;381:689.
    PubMed    


  56. VIOLO L, De Francesco M, Locatelli F
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;381:688-689.
    PubMed    


  57. CHANG KT, Lin HY
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;381:688.
    PubMed    


  58. BHOWMIK DM
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;381:687-688.
    PubMed    


    July 2019
  59. CHEN N, Hao C, Liu BC, Lin H, et al
    Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1901713.
    PubMed     Abstract available


  60. CHEN N, Hao C, Peng X, Lin H, et al
    Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1813599.
    PubMed     Abstract available


  61. KAPLAN J
    Roxadustat and Anemia of Chronic Kidney Disease.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMe1908978.
    PubMed    


    June 2019
  62. MACDOUGALL IC, Ford I
    Intravenous Iron and Maintenance Hemodialysis. Reply.
    N Engl J Med. 2019;380:e46.
    PubMed    


  63. AFSAR B, Elsurer Afsar R, Kanbay M
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    PubMed    


  64. NAKANISHI T, Kuragano T
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    PubMed    


  65. EISENGA MF, Bakker SJL, Gaillard CAJM
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    PubMed    


  66. AGARWAL R
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    PubMed    


    May 2019
  67. JOHNSON RJ, Wesseling C, Newman LS
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;380:1843-1852.
    PubMed    


    April 2019
  68. INGELFINGER JR, Rosen CJ
    Clinical Credence - SGLT2 Inhibitors, Diabetes, and Chronic Kidney Disease.
    N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMe1904740.
    PubMed    


  69. PERKOVIC V, Jardine MJ, Neal B, Bompoint S, et al
    Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
    N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMoa1811744.
    PubMed     Abstract available


  70. WOJCIECHOWSKI D, Gandhi RT, Rosales IA
    Case 11-2019: A 49-Year-Old Man with HIV Infection and Chronic Kidney Disease.
    N Engl J Med. 2019;380:1464-1472.
    PubMed    


    January 2019

  71. Timing of Renal-Replacement Therapy in Acute Kidney Injury and Sepsis.
    N Engl J Med. 2019;380:398-399.
    PubMed    


  72. XUE C, Zhou C, Xue D
    Timing of Renal-Replacement Therapy in Acute Kidney Injury and Sepsis.
    N Engl J Med. 2019;380:398-9.
    PubMed    



  73. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.
    N Engl J Med. 2019 Jan 14. doi: 10.1056/NEJMx180044.
    PubMed    


    October 2018
  74. MACDOUGALL IC, White C, Anker SD, Bhandari S, et al
    Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.
    N Engl J Med. 2018 Oct 26. doi: 10.1056/NEJMoa1810742.
    PubMed     Abstract available


  75. BARBAR SD, Clere-Jehl R, Bourredjem A, Hernu R, et al
    Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis.
    N Engl J Med. 2018;379:1431-1442.
    PubMed     Abstract available


  76. CAULLEY L
    A Seat at the Table.
    N Engl J Med. 2018;379:1400-1401.
    PubMed    


  77. BERNS JS, Glickman A, McCoy MS
    Dialysis-Facility Joint-Venture Ownership - Hidden Conflicts of Interest.
    N Engl J Med. 2018;379:1295-1297.
    PubMed    


    August 2018
  78. MARTINS JM, Magrico R
    Uremic Frost in End-Stage Renal Disease.
    N Engl J Med. 2018;379:669.
    PubMed    


    May 2018
  79. DELMONICO FL
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750-1.
    PubMed    


  80. CASTELLANO G, Cravedi P
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750.
    PubMed    


  81. KALLEN R
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750.
    PubMed    



  82. History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750-1752.
    PubMed    


    February 2018
  83. BERNS JS
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:584.
    PubMed    


  84. HOORN EJ, Vogt L, Rotmans JI
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:583-4.
    PubMed    


  85. URIBARRI J
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:583.
    PubMed    



  86. Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:583-585.
    PubMed    


  87. CALDERON-MARGALIT R, Golan E, Twig G, Leiba A, et al
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:428-438.
    PubMed     Abstract available


    December 2017
  88. COHEN SD, Kopp JB, Kimmel PL
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2017;377:2363-2374.
    PubMed    


    November 2017
  89. TORRES VE, Chapman AB, Devuyst O, Gansevoort RT, et al
    Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
    N Engl J Med. 2017;377:1930-1942.
    PubMed     Abstract available


  90. KALANTAR-ZADEH K, Fouque D
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2017;377:1765-1776.
    PubMed    


    October 2017
  91. SALY DL, Brewster UC, Sze GK, Louis ED, et al
    An Element of Unsteadiness.
    N Engl J Med. 2017;377:1379-1385.
    PubMed    


    August 2017
  92. MANN JFE, Orsted DD, Brown-Frandsen K, Marso SP, et al
    Liraglutide and Renal Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:839-848.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: